Pain Patient’s Right To Treatment

National Fibromyalgia & Chronic Pain Association 

The Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) have decreed that the United States is in the midst of a prescription opioid abuse epidemic; 17,000 overdose related deaths in 2012.  The unanticipated result of this decree is that people in pain who should be administered medications based on their physicians’ recommendations are being kept from adequate pain relief by pharmacies that in some instances have been filling the same prescriptions for more than ten years.


Blood Test vs. Urine Test






March 2014

Bernice Hecker, M.D.

Noridian Healthcare Solutions, LLC JE Part B Contractor Medical Director/s
Attention: Draft LCD Comments


NFMCPA Position on Step-Therapy

National Fibromyalgia & Chronic Pain Association Issues Position Paper Calling for End to Step-Therapy, Fail-First, and Specialty Tiers

LOGAN, Utah—10 October 2011---The National Fibromyalgia & Chronic Pain Association today issued a position paper that calls for an end to step-therapy, or fail-first, as insufficient treatment options which needlessly prolong the suffering of fibromyalgia and chronic pain patients.

The NFMCPA is the first nonprofit organization to issue a paper on this subject specifically addressing and advocating for the needs of the fibromyalgia and chronic pain patients.